Drug intelligence / Profile preview

COLD-FX Extra Strength

Development stage
Unknown
Lead developer
CV Technologies
Administration
Oral
01

Overview

COLD-FX Extra Strength is an over-the-counter botanical supplement developed and marketed by Bausch + Lomb Corporation (formerly Afexa Life Sciences) for immune support and the prevention of cold and flu symptoms. The active ingredient is CVT-E002, a proprietary polysaccharide-rich extract derived from the root of North American ginseng (*Panax quinquefolius*). Each capsule contains 300 mg of CVT-E002, which is a 4:1 extract equivalent to 1,200 mg of dried root. The product is indicated to help reduce the frequency, severity, and duration of cold and flu symptoms by boosting the immune system. Its mechanism of action involves the modulation of immune responses, including effects on cytokine production and the enhancement of innate immune cell activity, although the exact molecular targets are not fully characterized. It is regulated as a Natural Health Product in Canada.

Brand names
COLD-FX Extra Strength
Other names
North American Ginseng ExtractPanax quinquefolius extract
02

Targets

IL10 (Interleukin-10)

Beyond the preview

Go deeper on COLD-FX Extra Strength.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COLD-FX Extra Strength.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call